Monitor for future announcements regarding conversion of this evaluation into a commercial sale or expanded orders; follow-up deployments or contracts could signal growing market acceptance.
Price Chart
Executive Summary
Inspira Technologies announced the deployment of its FDA-cleared ART100 system at a top-ranked academic medical center in New York for a structured commercial evaluation. This expands its presence in the U.S. Tier-1 hospital market, supporting its commercial strategy, though no financial terms or outcomes were disclosed.
Key Facts
- Inspira Technologies deployed its ART100 system at a new U.S. academic medical center in New York.
- The institution is ranked among New York State’s top 10 hospitals in Newsweek’s World’s Best Hospitals 2025.
- The deployment is part of a structured commercial evaluation to assess clinical protocols and potential broader adoption.
- No financial figures, revenue impact, or contractual terms were disclosed.
- The ART100 is FDA-cleared for cardiopulmonary bypass in the U.S. and ECMO outside the U.S.
Financial Impact
No financial impact disclosed; no revenue, deal value, or guidance provided.
Risk Factors
- Evaluation may not lead to commercial adoption.
- No assurance of revenue generation from this deployment.
- Forward-looking statements are subject to risks and uncertainties as outlined in the company's 20-F filing.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3240229 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 18w ago | Press Release | $3.07 $1.61 | ▼ −47.56% | ▼ −45.76% | — |
May 18, 2026 19w ago | Press Release | $0.3723 $1.29 | ▲ +245.15% | ▲ +243.57% | — |
May 11, 2026 20w ago | Press Release | $0.4070 $1.60 | ▲ +293.12% | ▲ +293.42% | — |
May 1, 2026 22w ago | Press Release | $0.4680 $3.07 | ▲ +555.98% | ▲ +550.70% | — |
Apr 16, 2026 24w ago | Press Release | $0.4950 $0.4050 | ▼ −18.18% | ▼ −24.00% | — |
Apr 14, 2026 24w ago | Press Release | $0.4750 $0.4070 | ▼ −14.32% | ▼ −20.61% | — |
Apr 13, 2026 24w ago | Press Release | $0.5080 $0.4070 | ▼ −19.88% | ▼ −27.61% | — |
Apr 6, 2026 25w ago | Press Release | $0.4110 $0.4780 | ▲ +16.30% | ▲ +7.32% | — |
Apr 6, 2026 25w ago | Press Release | $0.4110 $0.4780 | ▲ +16.30% | ▲ +7.32% | — |
Mar 31, 2026 26w ago | Press Release | $0.4470 $0.4787 | ▲ +7.09% | ▼ −2.33% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access